MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Proceeds from exercise ofoptions$234K Net cash provided byfinancing activities$99K Canceled cashflow$135K Increase (decrease) incash-$4,913K Canceled cashflow$99K Accounts payable$2,558K Operating leaseright-of-use assets$1,383K Depreciation andamortization expense$1,377K Stock-based compensationexpense$1,237K Prepaid expenses andother current assets-$200K Loss on sale anddisposal of equipment-$111K Accrued liabilities$37K Allowance and estimatedcredit losses$28K Proceeds from sale ofequipment$24K Finance lease payments$135K Net cash provided by(used in) operating...-$4,472K Net cash used ininvesting activities-$540K Canceled cashflow$6,931K Canceled cashflow$24K Deferred revenue-$6,615K Purchase of property andequipment$564K Accounts receivable$2,002K Operating leaseliabilities-$1,586K Net income (loss)-$1,175K Other long term assets$16K Gain on terminationof operating lease$9K
Cash Flow

CHAMPIONS ONCOLOGY, INC. (CSBR)

CHAMPIONS ONCOLOGY, INC. (CSBR)

source: myfinsight.com